0.00Open0.00Pre Close0 Volume0 Open Interest20.00Strike Price0.00Turnover0.00%IV102.02%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier28DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.21Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Zuora Stock Discussion
up ⬆️⬆️⬆️⬆️⬆️
Today’s companies are looking for a new level of business agility to deploy new business models, launch product lines, and expand internationally. At the same time, they need their applications and platforms to help them scale to IPO and beyond. These new integrated solutions will deliver finance teams more agility, power enhanced subscription analytics, and make it easier than ever to deploy and adopt technology from two enterprise leaders.
$VIZIO (VZIO.US)$
$Fulgent Genetics (FLGT.US)$
$Cara Therapeutics (CARA.US)$
$KnowBe4 (KNBE.US)$
$Coursera (COUR.US)$
$Intellia Therapeutics (NTLA.US)$
$Natera (NTRA.US)$
$DraftKings (DKNG.US)$
$Natural Alternatives International (NAII.US)$
$Revolve Group (RVLV.US)$
$A10 Networks (ATEN.US)$
$Zuora (ZUO.US)$
Insider Buying
$Spero Therapeutics (SPRO.US)$
$Lumos Pharma (LUMO.US)$
$Oscar Health (OSCR.US)$
$Phibro Animal Health (PAHC.US)$
No comment yet